Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Nektar Therapeutics (NKTR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 3,450,536
  • Shares Outstanding, K 155,150
  • Annual Sales, $ 165,440 K
  • Annual Income, $ -153,520 K
  • 36-Month Beta 1.48
  • Price/Sales 20.79
  • Price/Cash Flow 0.00
  • Price/Book 76.23

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.78 +18.42%
on 06/27/17
22.82 -2.54%
on 07/21/17
+3.08 (+16.08%)
since 06/21/17
3-Month
17.33 +28.33%
on 05/09/17
22.82 -2.54%
on 07/21/17
+3.87 (+21.07%)
since 04/21/17
52-Week
11.41 +94.92%
on 01/31/17
24.88 -10.61%
on 03/29/17
+6.85 (+44.51%)
since 07/21/16

Most Recent Stories

More News
Nektar's NKTR-181 Positive in Human Abuse Potential Study

Positive top line results from an oral human abuse potential (HAP) study, evaluating the opioid analgesic candidate -- NKTR-181 -- to assess abuse potential compared with oxycodone, nudged up Nektar's...

COLL : 12.72 (+2.66%)
ENDP : 12.38 (+0.49%)
TEVA : 32.64 (+0.65%)
NKTR : 22.24 (+0.32%)
Nektar Therapeut has the Best Relative Performance in the Pharmaceuticals Industry (NKTR, SUPN, JNJ, DEPO, IPXL)

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

SUPN : 42.20 (-0.24%)
JNJ : 135.31 (-0.92%)
IPXL : 18.15 (+1.11%)
NKTR : 22.24 (+0.32%)
DEPO : 10.60 (-0.28%)
Watch for Nektar Therapeut to Potentially Pullback After Gaining 4.31% Yesterday

Nektar Therapeut (NASDAQ:NKTR) traded in a range yesterday that spanned from a low of $19.51 to a high of $20.45. Yesterday, the shares gained 4.3%, which took the trading range above the 3-day high...

NKTR : 22.24 (+0.32%)
Nektar Presents New Preclinical Data for NKTR-358, a First-in-Class Regulatory T Cell Stimulator, at 13th World Congress of Inflammation in London

Nektar Therapeutics (NASDAQ: NKTR) today announced positive preclinical results for NKTR-358, a first-in-class resolution therapeutic for autoimmune disease. The new preclinical data demonstrate that treatment...

NKTR : 22.24 (+0.32%)
Implied Volatility Surging for Nektar Therapeutics (NKTR) Stock Options

Nektar Therapeutics (NKTR) needs Investors to pay close attention to the stock based on moves in the options market lately.

NKTR : 22.24 (+0.32%)
Relatively Good Performance Detected in Shares of Ocular Therapeut in the Pharmaceuticals Industry (OCUL, DERM, HZNP, AERI, NKTR)

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

DERM : 29.40 (+2.80%)
AERI : 57.80 (+2.57%)
HZNP : 12.87 (-0.31%)
OCUL : 6.72 (-2.33%)
NKTR : 22.24 (+0.32%)
5 Reasons Why You Should Invest in AstraZeneca (AZN) in 2017

London-based pharma giant, AstraZeneca plc (AZN) has a strong product portfolio and is one of the key players in the global cardiovascular market.

AZN : 34.05 (+0.47%)
LLY : 84.66 (-0.11%)
AGN : 250.97 (+0.76%)
NKTR : 22.24 (+0.32%)
Nektar (NKTR) Stock Rallied Almost 50% This Year: Here's Why

Shares of Nektar Therapeutics (NKTR) are up almost 48% this year so far, outperforming the Zacks classified Medical-Drugs industry's registered increase of 3.6% during this period.

AZN : 34.05 (+0.47%)
AMGN : 180.21 (+0.50%)
BIIB : 282.92 (+0.53%)
NKTR : 22.24 (+0.32%)
SmarTrend Watching for Potential Rebound in Shares of Nektar Therapeutics After 7.85% Loss

Nektar Therapeutics (NASDAQ:NKTR) traded in a range yesterday that spanned from a low of $18.60 to a high of $20.73. Yesterday, the shares fell 7.8%, which took the trading range below the 3-day low...

NKTR : 22.24 (+0.32%)
Nektar Presents New Clinical Data from Two Studies of NKTR-214, a CD122-Biased Agonist, at 2017 American Society of Clinical Oncology (ASCO) Annual Meeting

Nektar Therapeutics (Nasdaq: NKTR) today announced that it presented new findings from two Phase 1 clinical studies of NKTR-214, Nektar's lead immuno-oncology candidate, a CD122-biased agonist, at the...

NKTR : 22.24 (+0.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

Nektar Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms, which are designed to meet unmet medical needs and improve the benefits of drugs for patients. Its product pipeline consists...

See More

Support & Resistance

2nd Resistance Point 23.19
1st Resistance Point 22.71
Last Price 22.24
1st Support Level 21.87
2nd Support Level 21.51

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.